Drug
VX 264
VX 264: highest development phase Phase 1/2, developed by Vertex Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Vertex Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| VX-264 NCT05791201 | Phase 1/2 | Type 1 Diabetes |
Latest
No recent events.
Follow VX 264 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.